SP-MHCI-0338-3

EBV Latent membrane protein 2 345-352, CPLSKILL

US$507.00

In stock

Description

About EBV Latent membrane protein 2 345-352, CPLSKILL

The Epstein-Barr Virus (EBV) (strain AG876) Latent membrane protein 2 Peptide (IEDB: 6808) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein Peptide, H-CPLSKILL-OH (Uniprot: Q1HVJ2 aa: 345-352) from JPT is produced under strict quality control and quality management.

EBV Latent membrane protein 2 345-352, CPLSKILL - Specifications

  • Peptide sequence: H-CPLSKILL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for EBV Latent membrane protein 2 345-352, CPLSKILL

References:
Read References with JPT’s Antigen Peptides
EBV Latent membrane protein 2 345-352, CPLSKILL has been described in:
Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope., J Immunol, 2006 (PMID: 16982932)
Cytolytic T lymphocytes from HLA-B8+ donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus., Herpesviridae, 2011 (PMID: 21429247)
Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities., J Immunol, 2005 (PMID: 15749866)

Documentation

Documentation for EBV Latent membrane protein 2 345-352, CPLSKILL

Properties

Properties of EBV Latent membrane protein 2 345-352, CPLSKILL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Epstein-Barr Virus (EBV)
Protein Name: Latent membrane protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to EBV Latent membrane protein 2 345-352, CPLSKILL

Information Values
Sequence: H-CPLSKILL-OH
Specifications: 8mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote